Bacteriophage therapy against American foulbrood in honey bees: a PRISMA-guided systematic review
Frontiers in Microbiology · 01.06.2026 · 17
DOI: 10.3389/fmicb.2026.1816537 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 01.06.2026. Verfasst von Nike Walter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department for Trauma Surgery, University Hospital Regensburg, Regensburg, Germany. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
American foulbrood (AFB), caused by the spore-forming bacterium Paenibacillus larvae , is the most destructive bacterial brood disease of Apis mellifera . Control is challenging because endospores persist for decades and antibiotic use is restricted by regulations, resistance, and residue concerns. Bacteriophages have re-emerged as a species-specific, residue-free strategy for AFB prevention and treatment. A PRISMA-guided systematic review was conducted searching PubMed, Embase, and Web of Science using the terms (bacteriophage OR phage) AND (honeybee OR Apis mellifera ). A total of 90 records were retrieved; after deduplication (19 removed), 71 titles and abstracts were screened. Eleven full texts were assessed for eligibility. Nine studies met inclusion criteria: three in adult bees or colonies, four in larvae, and two in vitro . Across studies, 27 P. larvae phages were characterized in vitro , 18 tested in larval assays, and nine evaluated at the hive level, mainly via oral delivery. In a controlled hive trial, a three-phage cocktail provided complete protection from natural AFB (100% protected vs. 80% infection in controls; p < 0.05) and enabled full recovery within 2 weeks, performing comparably to or better than prophylactic antibiotics. Larval studies generally showed significantly improved survival with prophylactic or therapeutic dosing, though efficacy varied by phage. A biodistribution study found limited indirect larval exposure after adult feeding (~32 PFU/larva at 24 h), indicating hive-mediated inactivation as a key translational barrier. One phage bound both vegetative cells and spores while retaining ~93% in-vitro infectivity. Overall, phage cocktails show strong proof-of-concept, with formulation, delivery, and rational cocktail design as key translational priorities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department for Trauma Surgery, University Hospital Regensburg, Regensburg, Germany.
- VOROS Fund for Regenerative Innovation, Vaduz, Liechtenstein.
- Institute of Virology, Helmholtz Centre Munich - German Research Centre for Environmental Health, Neuherberg, Germany.
- TUM School of Life Sciences, Central Institute of Infection Prevention (ZIP), Technical University of Munich, Freising, Germany.
- Department of Trauma, Hand and Reconstructive Surgery, University Hospital Giessen, Giessen, Germany.
Zitieren
APA
Walter, N., Bolte, A. T., Mirzaei, M. K., Deng, L., & Rupp, M. (2026). Bacteriophage therapy against American foulbrood in honey bees: a PRISMA-guided systematic review. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1816537
Vancouver
Walter N, Bolte AT, Mirzaei MK, Deng L, Rupp M. Bacteriophage therapy against American foulbrood in honey bees: a PRISMA-guided systematic review. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1816537
BibTeX
@article{Walter2026,
author = {Walter, Nike and Bolte, Aaron Teja and Mirzaei, Mohammadali Khan and Deng, Li and Rupp, Markus},
title = {Bacteriophage therapy against American foulbrood in honey bees: a PRISMA-guided systematic review},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1816537}
}
EUVIMED